* SNDL Inc SNDL.OQ reported a quarterly adjusted loss of 7
cents per share for the quarter ended September 30. The lone
analyst forecast for the quarter was for a loss of 5 cents per
share.
* Revenue was $236.89 million; analysts expected $232.40
million.
* SNDL Inc's reported EPS for the quarter was a loss of 7
cents.
* SNDL Inc shares had risen by 4.9% this quarter and
gained 31.7%
so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"
Wall Street's median 12-month price target for SNDL Inc is 3.50
This summary was machine generated from LSEG data November 6 at
04:59 a.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 -0.05 -0.07 Missed